{
  "documentMetadata": {
    "title": "Brain Abscess, Nocardia",
    "lastUpdated": "2024-09-16",
    "sourceFile": "Brain Abscess, Nocardia.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Usually occurs in immunocompromised hosts, often with concomitant pulmonary infection or other evidence of disseminated disease.",
        "May occur with meningitis and/or ventriculitis."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Over 40 species of Nocardia have been identified in human infections (Clin Microbiol Rev. 2006; 19:259; Clin Microbiol Rev. 2022; 35:e0002721). The more common are listed below.",
        "Nocardia nova complex",
        "Nocardia farcinica",
        "Nocardia cyriacigeorgica",
        "Nocardia brasiliensis",
        "Nocardia abscessus"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "list",
      "items": [
        "Consider surgical drainage for larger absceses"
      ]
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "TMP-SMX",
            "dose": "(15 mg/kg/day TMP), (75 mg/kg/day SMX)",
            "route": "IV/po",
            "frequency": "divided in 2-4 doses"
          },
          {
            "drug": "Imipenem-cilastatin",
            "dose": "500 mg",
            "route": "IV",
            "frequency": "q6h",
            "connector": "+"
          }
        ]
      }
    },
    {
      "type": "list",
      "items": [
        "If multiorgan involvement some add Amikacin 7.5 mg/kg q12h.",
        "See Antimicrobial Stewardship for duration of therapy and oral step-down."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Linezolid",
            "dose": "600 mg",
            "route": "IV or po",
            "frequency": "q12h"
          },
          {
            "drug": "Meropenem",
            "dose": "2 gm",
            "route": "IV",
            "frequency": "q8h",
            "connector": "+"
          }
        ]
      }
    },
    {
      "type": "list",
      "items": [
        "See Comments for duration of therapy and oral stepdown."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Duration of treatment:"
        },
        {
          "type": "list",
          "items": [
            "After 3-6 weeks of IV therapy (prefer 6 weeks for immuncompromised patients, those with extensive disease), switch to po therapy.",
            "Immunocompetent patients: TMP-SMX, Minocycline or Amoxicillin-clavulanate x 3 or more months (longer for meningitis, extensive disease).",
            "Immunocompromised patients: Treat with 2 drugs for at least one year."
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Susceptibility tested should be performed to guide therapy.",
        "TMP-SMX remains a drug of choice for CNS nocardia infection",
        "If organism is sulfonamide-resistant or patient is sulfa-allergic, use Amikacin plus one of Imipenem, Meropenem, Ceftriaxone.",
        "N. farcinica is resistant to Ceftriaxone and it should not be used for treatment of infection caused by this organism."
      ]
    }
  ]
}
